Delivery Order SPE2DR25D3005-SPE2DR26FP8GN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,409.73 to AmerisourceBergen Drug Corp for Glatopa 20 mg/ml syringes, with performance in Conshohocken, Pennsylvania and completion targeted for November 17, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a larger indefinite delivery contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for Glatopa 40 mg/mL syringes with a ceiling value of $5,937.39. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents a non-competitive set-aside and is being performed at the contractor's Conshohocken facility. The award falls under AmerisourceBergen's...
- The Defense Logistics Agency Troop Support Medical awarded a $18,634.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for GLATOPA 40 MG/ML SYRINGEML. The place of performance is Conshohocken, Pennsylvania. The period of performance is from August 2, 2023 through August 3, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with a larger indefinite-delivery/indefinite-quantity contract vehicle. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Glatiramer 40 mg/ml syringes, valued at $5,083.61. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the agency's pharmaceutical procurement strategy through established contract vehicles....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Glatiramer 40 mg/ml syringes valued at $5,860.02, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $6,684.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561636287 GLATOPA 40 MG/ML SYRINGEML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill agency requirements. Performance will take place between July 28 and July 31, 2023. No set aside designation or subcontractors...
- The Defense Logistics Agency awarded a delivery order valued at $2,930.01 to AmerisourceBergen Drug Corp for Glatiramer 40 mg/mL syringes. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under a larger indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $9,086.82 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561807048 GLATOPA 40 MG/ML SYRINGEML. The place of performance is Conshohocken, Pennsylvania. The contract period is from August 14, 2023 through August 15, 2023. Under this contract, Amerisourcebergen will provide pharmaceutical products to the Defense Logistics Agency in support of the Agency's mission to provide logistics support for the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of GLATOPA 20 MG/ML SYRINGE/ML, with a potential value of $1,577.13. The contract has a completion date of November 15, 2022 and was awarded on November 14, 2022. No set-aside designation was used. Amerisourcebergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $2,930.01 to AmerisourceBergen Drug Corp for Glatiramer 40 mg/ml syringes, with an ultimate completion date of June 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8GNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,146.82 to AmerisourceBergen Drug Corp for Glatopa 20 mg/ml syringes, with an ultimate completion date of December 31, 2025. This is a firm fixed price, non-set-aside contract issued as a child order under a larger indefinite delivery vehicle. The product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The Defense Logistics Agency's Medical Supply Chain relies on such prime vendor contracts to ensure consistent availability of critical pharmaceutical commodities for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/29/25 |